394 related articles for article (PubMed ID: 18043472)
21. Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.
Iravani M; Mousavi A; Gholibeikian S; Bahar B; Samiee S; Ashouri A; Eghbal L; Ghavamzadeh A
Bone Marrow Transplant; 2005 Jun; 35(11):1095-9. PubMed ID: 15821773
[TBL] [Abstract][Full Text] [Related]
22. Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft-versus-host disease.
Przepiorka D; Shapiro S; Schwinghammer TL; Bloom EJ; Rosenfeld CS; Shadduck RK; Venkataramanan R
Bone Marrow Transplant; 1991 Jun; 7(6):461-5. PubMed ID: 1873593
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
[TBL] [Abstract][Full Text] [Related]
24. The safety and efficacy of acute graft-versus-host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL.
Machishima T; Kako S; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Ashizawa M; Terasako K; Kimura S; Kikuchi M; Nakasone H; Kanda J; Yamazaki R; Nishida J; Kanda Y
Clin Transplant; 2013; 27(5):749-56. PubMed ID: 24033855
[TBL] [Abstract][Full Text] [Related]
25. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
Ayuk F; Diyachenko G; Zabelina T; Wolschke C; Fehse B; Bacher U; Erttmann R; Kröger N; Zander AR
Biol Blood Marrow Transplant; 2008 Aug; 14(8):913-9. PubMed ID: 18640575
[TBL] [Abstract][Full Text] [Related]
26. Graft-versus-leukemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia: significantly lower relapse rate in unrelated transplantations.
Gassas A; Sung L; Saunders EF; Doyle J
Bone Marrow Transplant; 2007 Nov; 40(10):951-5. PubMed ID: 17873916
[TBL] [Abstract][Full Text] [Related]
27. Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease.
Kumar S; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Harmsen WS; Litzow MR
Bone Marrow Transplant; 2001 Jun; 27(11):1133-40. PubMed ID: 11551023
[TBL] [Abstract][Full Text] [Related]
28. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
29. Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents.
Remberger M; Ringdén O
Transplantation; 2007 Aug; 84(4):551-4. PubMed ID: 17713443
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine-induced pain syndrome in a child undergoing hematopoietic stem cell transplant.
Lavoratore SR; Navarro OM; Grunebaum E; Ali M; Koo A; Schechter T; Gassas A; Doyle JJ; Lee Dupuis L
Ann Pharmacother; 2009 Apr; 43(4):767-71. PubMed ID: 19318596
[TBL] [Abstract][Full Text] [Related]
31. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
[TBL] [Abstract][Full Text] [Related]
32. Incidence, etiology, and risk factors for liver dysfunction in children following hematopoietic stem cell transplantation.
Subbarao G; Haut PR; Johnson CS; Gowan D; Molleston JP
Pediatr Transplant; 2006 Sep; 10(6):682-9. PubMed ID: 16911491
[TBL] [Abstract][Full Text] [Related]
33. Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin.
Sedlácek P; Formánková R; Keslová P; Srámková L; Hubácek P; Król L; Kulich M; Starý J
Bone Marrow Transplant; 2006 Dec; 38(11):745-50. PubMed ID: 17041606
[TBL] [Abstract][Full Text] [Related]
34. Ocular findings after allogeneic hematopoietic stem cell transplantation.
Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
[TBL] [Abstract][Full Text] [Related]
35. Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants.
Hoyt R; Ritchie DS; Roberts AW; Macgregor L; Curtis DJ; Szer J; Grigg AP
Bone Marrow Transplant; 2008 Apr; 41(7):651-8. PubMed ID: 18176619
[TBL] [Abstract][Full Text] [Related]
36. CsA exposure is associated with acute GVHD and relapse in children after SCT.
Willemze AJ; Press RR; Lankester AC; Egeler RM; den Hartigh J; Vossen JM
Bone Marrow Transplant; 2010 Jun; 45(6):1056-61. PubMed ID: 19881556
[TBL] [Abstract][Full Text] [Related]
37. Low cyclosporine concentrations in children and time to acute graft versus host disease.
Chung EK; Yee J; Kim JY; Gwak HS
BMC Pediatr; 2020 May; 20(1):206. PubMed ID: 32393210
[TBL] [Abstract][Full Text] [Related]
38. Outcome of pediatric hematopoietic stem cell transplantations from Thai unrelated donors matched with high-resolution HLA typing.
Vanichsetakul P; O-Charoen R; Seksarn P; Kupatawintu P
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S1-6. PubMed ID: 16622993
[TBL] [Abstract][Full Text] [Related]
39. Are HLA antigens a risk factor for acute GVHD in thalassemic patients receiving HLA-identical stem cell transplantation?
Mohyeddin Bonab M; Alimoghaddam K; Vatandoust S; Forouzia F; Jahani M; Ghavamzadeh A
Transplant Proc; 2004 Dec; 36(10):3190-3. PubMed ID: 15686726
[TBL] [Abstract][Full Text] [Related]
40. Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation.
Forslöw U; Mattsson J; Ringden O; Klominek J; Remberger M
Scand J Infect Dis; 2006; 38(11-12):970-6. PubMed ID: 17148063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
